ArticleResearch square2025
Association of Nociplastic Pain Features with Function in Aging Veterans with Chronic Low Back Pain.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Chronic low back pain (CLBP) affects nearly one million Veterans and is a leading cause of disability. Nociplastic pain, characterized by altered central nervous system processing, widespread pain and sleep disturbance, may negatively impact treatment response in this population, yet remains underrecognized. Objective: Determine the prevalence and association of nociplastic features with function among aging Veterans with CLBP. Design: Cross-sectional survey of Veterans aged 50-89 years with CLBP identified through VA administrative data. A stratified random sampling design oversampled women and Black/African-American veterans. Participants: Of 800 invited, 361 responded (45.1% response rate); after excluding those without CLBP, 342 participants were included (mean age 69.2 years, 19.2% women, 17.8% Black/African-American). Main Measures: Nociplastic features were assessed using the Fibromyalgia Survey Questionnaire to calculate a fibromyalgia severity score. Function was assessed via the Veterans RAND 12-Item Health Survey (VR-12) Physical (PCS) and Mental Component Summary (MCS) scores. Regression models adjusted for sociodemographics, comorbidities, opioid use, pain intensity, and surgical history. Key Results: Nociplastic characteristics were highly prevalent (fibromyalgia severity score mean 11.3, SD 5.9). Overall, 36% screened positive for fibromyalgia via American College of Rheumatology criteria, however, over half of respondents aged 50-64 years met criteria. Widespread pain was common; on average, pain was experienced in six discrete locations. Physical function was severely impaired (mean VR-12 PCS 30.2, nearly 2 SD below population norms); psychological function was moderately impaired (mean MCS 45). Higher fibromyalgia severity scores independently associated with poorer physical function (β= -0.30 per point increase, 95% CI -0.49, -0.12; Conclusions: Nociplastic features are highly prevalent in aging Veterans with CLBP and demonstrate a dose-response relationship with impaired functioning. Recognition may guide more effective, mechanism-based treatment approaches and reduce harm.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.